Tag - novavax

 
 

NOVAVAX

Japan Times
WORLD
Dec 21, 2021
EU backs Novavax shot as region's fifth COVID-19 vaccine
It is not clear yet how Novavax performs against the omicron variant, or whether a booster dose will be needed.
Japan Times
JAPAN
Sep 7, 2021
Japan secures 150 million Novavax vaccine doses
Known as TAK-019 in Japan, the vaccine has proved to be 90% effective in preventing infections at clinical trials held abroad.
Japan Times
COMMENTARY / World
Jun 19, 2021
A vaccine the world badly needs looks better than ever
The vaccine is also more stable and easily stored than mRNA vaccines, which will be helpful in broad distribution.
Japan Times
WORLD
Jun 15, 2021
Novavax COVID-19 shot highly effective against variants in trial
The company plans to apply for regulatory clearance globally, with much of the first available doses going to low- and middle-income countries.
Japan Times
JAPAN / Science & Health
Feb 24, 2021
Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan
The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.
Japan Times
WORLD
Jan 29, 2021
COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says
The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.
Japan Times
WORLD / Science & Health
Jan 20, 2021
South Korea in talks to secure 40 million doses of Novavax vaccine
South Korea is in talks to purchase 40 million doses of a coronavirus vaccine developed by Novavax, its local manufacturer SK Bioscience said Wednesday.

Longform

Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on